We've found
2,815
archived clinical trials in
Parkinsons Disease
We've found
2,815
archived clinical trials in
Parkinsons Disease
A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders
Updated: 2/8/2017
An Open Label, Multicenter Study, Evaluating the Safety and Efficacy of 18F-AV-133 PET Imaging to Identify Subjects With Dopaminergic Degeneration Among Subjects Presenting to a Movement Disorders Specialty Clinic With an Uncertain Diagnosis
Status: Enrolling
Updated: 2/8/2017
A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders
Updated: 2/8/2017
An Open Label, Multicenter Study, Evaluating the Safety and Efficacy of 18F-AV-133 PET Imaging to Identify Subjects With Dopaminergic Degeneration Among Subjects Presenting to a Movement Disorders Specialty Clinic With an Uncertain Diagnosis
Status: Enrolling
Updated: 2/8/2017
Click here to add this to my saved trials
A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders
Updated: 2/8/2017
An Open Label, Multicenter Study, Evaluating the Safety and Efficacy of 18F-AV-133 PET Imaging to Identify Subjects With Dopaminergic Degeneration Among Subjects Presenting to a Movement Disorders Specialty Clinic With an Uncertain Diagnosis
Status: Enrolling
Updated: 2/8/2017
A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects With Parkinson's Disease (PD) From Other Movement Disorders
Updated: 2/8/2017
An Open Label, Multicenter Study, Evaluating the Safety and Efficacy of 18F-AV-133 PET Imaging to Identify Subjects With Dopaminergic Degeneration Among Subjects Presenting to a Movement Disorders Specialty Clinic With an Uncertain Diagnosis
Status: Enrolling
Updated: 2/8/2017
Click here to add this to my saved trials
Movement Disorder Quantification Algorithm Development
Status: Enrolling
Updated: 2/22/2017
Updated: 2/22/2017
Movement Disorder Quantification Algorithm Development
Status: Enrolling
Updated: 2/22/2017
Updated: 2/22/2017
Click here to add this to my saved trials
Dance Exercise as Novel Complementary Therapy for Parkinson's Disease
Updated: 3/15/2017
Dance Exercise as Novel Complementary Therapy for Parkinson's Disease
Status: Enrolling
Updated: 3/15/2017
Dance Exercise as Novel Complementary Therapy for Parkinson's Disease
Updated: 3/15/2017
Dance Exercise as Novel Complementary Therapy for Parkinson's Disease
Status: Enrolling
Updated: 3/15/2017
Click here to add this to my saved trials
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
Updated: 3/20/2017
Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3154207 in Healthy Subjects and Subjects With Parkinson's Disease
Status: Enrolling
Updated: 3/20/2017
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
Updated: 3/20/2017
Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3154207 in Healthy Subjects and Subjects With Parkinson's Disease
Status: Enrolling
Updated: 3/20/2017
Click here to add this to my saved trials
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
Updated: 3/20/2017
Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3154207 in Healthy Subjects and Subjects With Parkinson's Disease
Status: Enrolling
Updated: 3/20/2017
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
Updated: 3/20/2017
Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3154207 in Healthy Subjects and Subjects With Parkinson's Disease
Status: Enrolling
Updated: 3/20/2017
Click here to add this to my saved trials
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
Updated: 3/20/2017
Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3154207 in Healthy Subjects and Subjects With Parkinson's Disease
Status: Enrolling
Updated: 3/20/2017
A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease
Updated: 3/20/2017
Multiple-Ascending Dose, Safety, Tolerability, and Pharmacokinetic Study of LY3154207 in Healthy Subjects and Subjects With Parkinson's Disease
Status: Enrolling
Updated: 3/20/2017
Click here to add this to my saved trials
Efficacy Study of Amantadine to Treat Gait Dysfunction and Freezing in Parkinson's Disease
Updated: 3/28/2017
Efficacy of Amantadine for Gait Dysfunction and Gait Freezing in Patients With Parkinson's Disease
Status: Enrolling
Updated: 3/28/2017
Efficacy Study of Amantadine to Treat Gait Dysfunction and Freezing in Parkinson's Disease
Updated: 3/28/2017
Efficacy of Amantadine for Gait Dysfunction and Gait Freezing in Patients With Parkinson's Disease
Status: Enrolling
Updated: 3/28/2017
Click here to add this to my saved trials
An Open-label Safety Study of Pimavanserin in Parkinson's Disease Patients
Status: Enrolling
Updated: 4/18/2017
Updated: 4/18/2017
An Open-label Safety Study of Pimavanserin in Parkinson's Disease Patients
Status: Enrolling
Updated: 4/18/2017
Updated: 4/18/2017
Click here to add this to my saved trials
Long-term Effect of Low Frequency Stimulation on Aspiration and Freezing of Gait in PD With STN DBS
Updated: 6/5/2017
Long-term Effect of Low Frequency 60Hz Stimulation on Aspiration, Freezing of Gait and Other Axial and Motor Symptoms in PD Patients With Bilateral STN DBS
Status: Enrolling
Updated: 6/5/2017
Long-term Effect of Low Frequency Stimulation on Aspiration and Freezing of Gait in PD With STN DBS
Updated: 6/5/2017
Long-term Effect of Low Frequency 60Hz Stimulation on Aspiration, Freezing of Gait and Other Axial and Motor Symptoms in PD Patients With Bilateral STN DBS
Status: Enrolling
Updated: 6/5/2017
Click here to add this to my saved trials
Telemedicine Intervention to Improve Physical Function
Updated: 6/22/2017
A Telemedicine Intervention to Improve Physical Function in Patients With PD
Status: Enrolling
Updated: 6/22/2017
Telemedicine Intervention to Improve Physical Function
Updated: 6/22/2017
A Telemedicine Intervention to Improve Physical Function in Patients With PD
Status: Enrolling
Updated: 6/22/2017
Click here to add this to my saved trials
Mobile Health Technology to Promote Physical Activity in Persons With Parkinson Disease
Updated: 7/18/2017
Mobile Health Technology to Promote Physical Activity in Persons With Parkinson Disease
Status: Enrolling
Updated: 7/18/2017
Mobile Health Technology to Promote Physical Activity in Persons With Parkinson Disease
Updated: 7/18/2017
Mobile Health Technology to Promote Physical Activity in Persons With Parkinson Disease
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials
A Multifactorial Exercise Program to Reduce Falls in People With Parkinson Disease
Updated: 7/18/2017
A Multifactorial Exercise Program to Reduce Falls in People With Parkinson Disease
Status: Enrolling
Updated: 7/18/2017
A Multifactorial Exercise Program to Reduce Falls in People With Parkinson Disease
Updated: 7/18/2017
A Multifactorial Exercise Program to Reduce Falls in People With Parkinson Disease
Status: Enrolling
Updated: 7/18/2017
Click here to add this to my saved trials
Uncovering an Electrical Biomarker for Freezing of Gait in Parkinson's Disease
Updated: 7/25/2017
Uncovering an Electrical Biomarker for Freezing of Gait in Parkinson's Disease
Status: Enrolling
Updated: 7/25/2017
Uncovering an Electrical Biomarker for Freezing of Gait in Parkinson's Disease
Updated: 7/25/2017
Uncovering an Electrical Biomarker for Freezing of Gait in Parkinson's Disease
Status: Enrolling
Updated: 7/25/2017
Click here to add this to my saved trials
The Impact of Three Distinct Exercise Types on Fatigue, Anxiety, and Depression in Parkinson's Disease
Updated: 7/25/2017
The Impact of Three Distinct Exercise Types on Fatigue, Anxiety, and Depression in Parkinson's Disease
Status: Enrolling
Updated: 7/25/2017
The Impact of Three Distinct Exercise Types on Fatigue, Anxiety, and Depression in Parkinson's Disease
Updated: 7/25/2017
The Impact of Three Distinct Exercise Types on Fatigue, Anxiety, and Depression in Parkinson's Disease
Status: Enrolling
Updated: 7/25/2017
Click here to add this to my saved trials
Motion Immune Magnetic Resonance Imaging (MRI)
Updated: 8/10/2017
Examining the Clinical Utility of Motion Immune MRI Across Multiple Patient Populations
Status: Enrolling
Updated: 8/10/2017
Motion Immune Magnetic Resonance Imaging (MRI)
Updated: 8/10/2017
Examining the Clinical Utility of Motion Immune MRI Across Multiple Patient Populations
Status: Enrolling
Updated: 8/10/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Updated: 8/16/2017
A Placebo-Controlled Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Status: Enrolling
Updated: 8/16/2017
Click here to add this to my saved trials
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
Updated: 9/4/2017
A Double-Blind, Placebo-Controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan in Patients With Parkinson's Disease Suffering From Treatment-Associated Dyskinesia
Status: Enrolling
Updated: 9/4/2017
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
Updated: 9/4/2017
A Double-Blind, Placebo-Controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan in Patients With Parkinson's Disease Suffering From Treatment-Associated Dyskinesia
Status: Enrolling
Updated: 9/4/2017
Click here to add this to my saved trials
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
Updated: 9/4/2017
A Double-Blind, Placebo-Controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan in Patients With Parkinson's Disease Suffering From Treatment-Associated Dyskinesia
Status: Enrolling
Updated: 9/4/2017
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
Updated: 9/4/2017
A Double-Blind, Placebo-Controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan in Patients With Parkinson's Disease Suffering From Treatment-Associated Dyskinesia
Status: Enrolling
Updated: 9/4/2017
Click here to add this to my saved trials
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
Updated: 9/4/2017
A Double-Blind, Placebo-Controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan in Patients With Parkinson's Disease Suffering From Treatment-Associated Dyskinesia
Status: Enrolling
Updated: 9/4/2017
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
Updated: 9/4/2017
A Double-Blind, Placebo-Controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan in Patients With Parkinson's Disease Suffering From Treatment-Associated Dyskinesia
Status: Enrolling
Updated: 9/4/2017
Click here to add this to my saved trials
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
Updated: 9/4/2017
A Double-Blind, Placebo-Controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan in Patients With Parkinson's Disease Suffering From Treatment-Associated Dyskinesia
Status: Enrolling
Updated: 9/4/2017
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
Updated: 9/4/2017
A Double-Blind, Placebo-Controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan in Patients With Parkinson's Disease Suffering From Treatment-Associated Dyskinesia
Status: Enrolling
Updated: 9/4/2017
Click here to add this to my saved trials
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
Updated: 9/4/2017
A Double-Blind, Placebo-Controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan in Patients With Parkinson's Disease Suffering From Treatment-Associated Dyskinesia
Status: Enrolling
Updated: 9/4/2017
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
Updated: 9/4/2017
A Double-Blind, Placebo-Controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan in Patients With Parkinson's Disease Suffering From Treatment-Associated Dyskinesia
Status: Enrolling
Updated: 9/4/2017
Click here to add this to my saved trials
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
Updated: 9/4/2017
A Double-Blind, Placebo-Controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan in Patients With Parkinson's Disease Suffering From Treatment-Associated Dyskinesia
Status: Enrolling
Updated: 9/4/2017
Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia
Updated: 9/4/2017
A Double-Blind, Placebo-Controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety and Efficacy of Sarizotan in Patients With Parkinson's Disease Suffering From Treatment-Associated Dyskinesia
Status: Enrolling
Updated: 9/4/2017
Click here to add this to my saved trials